Fresenius SE & Co KGaA Registered Shares

FRE: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
qFLOCK|V^ykkLOCK|Y@?C?#^

Fresenius SE Earnings: New Products Power Its Rejuvenate Strategy; Raise Fair Value Estimate 8%

Fresenius SE reported fourth-quarter 2025 organic sales growth of 7%, at the high end of its organic sales guidance, and ahead of company-compiled consensus, driven by both the Kabi and Helios segments. The EBIT increased 6% in constant currencies, in line with consensus.

Sponsor Center